A Kleinjan

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism
    A Kleinjan
    A Kleinjan, MD, Department of Vascular Medicine, Room F4 147, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, Tel 31 20 5665975, Fax 31 20 5669343, E mail
    Thromb Haemost 110:959-65. 2013
  2. doi Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study
    Frederiek van Doormaal
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Thromb Haemost 108:160-5. 2012
  3. ncbi Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism
    A Kleinjan
    Department of Vascular Medicine, Academic Medical Center in Amsterdam, Amsterdam, The Netherlands
    Neth J Med 70:311-7. 2012
  4. ncbi Cell-derived microvesicles and cancer
    F F van Doormaal
    Departments of Vascular Medicine and Clinical Chemistry, Academic Medical Centre, Amsterdam, The Netherlands
    Neth J Med 67:266-73. 2009

Collaborators

Detail Information

Publications4

  1. ncbi A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism
    A Kleinjan
    A Kleinjan, MD, Department of Vascular Medicine, Room F4 147, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands, Tel 31 20 5665975, Fax 31 20 5669343, E mail
    Thromb Haemost 110:959-65. 2013
    ..In contrast, the dose of LMWH and the type of anticoagulant chosen after the initial 3-12 months varied substantially, probably reflecting the limited available evidence. ..
  2. doi Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study
    Frederiek van Doormaal
    Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    Thromb Haemost 108:160-5. 2012
    ..However, in the patients who developed VTE within six months when compared to those who did not, an increased MP procoagulant activity was present already at baseline, suggesting this activity can be used to predict VTE...
  3. ncbi Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism
    A Kleinjan
    Department of Vascular Medicine, Academic Medical Center in Amsterdam, Amsterdam, The Netherlands
    Neth J Med 70:311-7. 2012
    ..Here, the costs and test characteristics of these screening strategies are presented, including true- and false-positive findings, sensitivity and specificity...
  4. ncbi Cell-derived microvesicles and cancer
    F F van Doormaal
    Departments of Vascular Medicine and Clinical Chemistry, Academic Medical Centre, Amsterdam, The Netherlands
    Neth J Med 67:266-73. 2009
    ..Here, we will present an overview of the many contributions of microvesicles to cancer development and progression. In addition, their role in risk stratification and treatment of cancer patients is discussed...